Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study

Article full textThe full text of this article can be found here https://link.springer.com/article/10.1007/s12325-017-0626-4.Provide enhanced content for this articleIf you are an author of this publication and would like to provide additional enhanced content for your article then please contact [e-mail] journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.Other enhanced features include, but are not limited to:Summary slidesSlide decksVideos and animationsAudio abstractsAudio slides

本文全文可在此处查阅：https://link.springer.com/article/10.1007/s12325-017-0626-4。如为该出版物之作者，并希望为文章提供额外增强内容，请通过[e-mail]与我们联系。本刊提供一系列旨在提升可见度和阅读量的附加功能。所有这些功能都将经过严格的同行评审，以确保内容的科学标准达到最高水平，并且所有附加功能均标注为‘同行评审’，以使读者了解其内容已达到与所展示文章相同的评审标准。此外，所有赞助和披露信息均包含在内，以确保完全透明并遵守良好的出版实践。这确保了无论内容如何获取，读者都能全面了解其来源。提供额外开放获取内容不收取任何费用。其他增强功能包括但不限于：摘要幻灯片、演示文稿、视频和动画、音频摘要、音频幻灯片。